Brooks Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2025
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brooks Laboratories Limited held its 23rd AGM on September 26, 2025, via video conferencing, chaired by Independent Director Dr. Usha Singh. 88 members attended personally and the meeting concluded in just 14 minutes (9:00 AM to 9:14 AM). Five ordinary resolutions were tabled, including approval of audited financial statements for FY ending March 31, 2025, reappointment of Wholetime Director Bhushan Singh Rana, appointment of the Secretarial Auditor, ratification of Cost Auditor's remuneration, and approval of related party transactions. Three special resolutions were also put forward covering potential restructuring activities (merger, demerger, slump sale, amalgamation), disposal or transfer of the company's investment in Brooks Steriscience Limited, and alteration of the Memorandum of Association. Voting results will be submitted separately within two working days. No shareholder speakers participated during the meeting.
Shareholders should watch for the upcoming e-voting results, especially on the special resolutions, as they could signal upcoming corporate restructuring activity — including the possible exit from Brooks Steriscience Limited — which may materially affect the company's structure and shareholder value.